YKL-1-116 is a potent, selective and covalent inhibitor of CDK7. References: Kalan S, Amat R, Schachter MM, Kwiatkowski N, Abraham BJ, Liang Y, Zhang T, Olson CM, Larochelle S, Young RA, Gray NS, Fisher RP. Activation of the p53 Transcriptional Program Sensitizes Cancer Cells to Cdk7 Inhibitors. Cell Rep. 2017 Oct 10;21(2):467-481. doi: 10.1016/j.celrep.2017.09.056. PubMed PMID: 29020632; PubMed Central PMCID: PMC5687273.

纯度：≥98%

CAS：1957202-71-9